Olga Potapova
Cureline, Inc., USA
Biography
Olga Potapova is a life sciences executive with extensive scientific and project management expertise in translational oncology, diagnostics and laboratory medicine. She worked on development of targeted therapies (SUTENT) and human prenatal diagnostic tests (Cystic Fibrosis); coordinated major international collaboration projects with an emphasis on RTK signal transduction research, human biospecimen procurement, preclinical and early clinical development. Currently Dr. Potapova leads Cureline, a Human Biospecimen CRO providing services for drug discovery, biomarker research and companion diagnostics development. Olga received multiple AACR/AFLAC awards, NIH and NATO fellowships, and has published multiple scientific papers in peer-reviewed journals. Since 2010, Dr. Potapova has been a Principal Investigator for The Cancer Genome Atlas (TCGA) program. She has advanced degrees in Physics and in Molecular Genetics/Biochemistry.
Abstract
Abstract : International Biobanking of Human Biospecimens for Precision Medicine
